Please provide your email address to receive an email when new articles are posted on . The FDA approved Nemluvio (nemolizumab-ilto) to treat adults with prurigo nodularis. The approval was supported ...

Nemolizumab showed statistically significant improvements in the coprimary endpoints of IGA success and EASI-75 compared with placebo. The Food and Drug Administration (FDA) has approved Nemluvio ® ...

Galderma on Tuesday said the Food and Drug Administration has approved its antibody drug Nemluvio for adults with prurigo nodularis, a chronic skin condition characterized by intense itch. A ...

People with atopic dermatitis often need to use many medicines every day to help with their itchiness and rashes. There are treatment options that can be applied directly to the skin (also known as ...

Medically reviewed by Patricia Mikula, PharmD Key Takeaways Biologics are used for people with severe eczema when other ...

"Itch is the most common symptom of atopic dermatitis, but the impact of itch is often more than skin deep. Unrelenting itch can have a significant emotional burden, with patients experiencing anxiety ...

Please provide your email address to receive an email when new articles are posted on . Nemluvio’s approved indications include atopic dermatitis in patients aged 12 years and older and prurigo ...

Aiming to offer an advantage over Dupixent (dupilumab, Regeneron Pharmaceuticals Inc.), dermatology-focused Galderma Holding SA won clearance from the U.S. FDA for Nemluvio (nemolizumab) as a ...